LJ McGarry scite author profile

Sensitivity analyses eliminating T315I status from the weighting yielded similar results. ConClusions: Adjusted ponatinib efficacy outcomes in third-line CP-CML were similar to unadjusted, and efficacy was more than double that observed with bosutinib, irrespective of T315I mutation status. These results suggest that the higher efficacy observed is PACE (ponatinib) versus the bosutinib trial is not due to bias in patient selection.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

LJ McGarry

Psy23 Cost-Effectiveness of Laparoscopic Adjustable Gastric Banding and Laparoscopic Roux-en-Y Gastric Bypass in the Treatment of Morbid Obesity

Psy7 the Budgetary Impact of Including Laparoscopic Adjustable Gastric Banding as a Covered Surgical Treatment for Morbidly Obese Adults in a Managed Care Population

Cs2 Cost-Effectiveness of Competing Antipsychotic Monotherapies in Acute Bipolar Mania in the U.K.

Pmh26: Cost-Effectiveness of Atypical Antipsychotics in Acute Bipolar Mania

Indirect Comparison Of Efficacy Of PonatiniB Versus Bosutinib In 3rd-Line Chronic-Phase Chronic Myeloid Leukemia Using Iterative Proportional Fitting

Contact Info

Product

Resources

About